SBP 002

Drug Profile

SBP 002

Alternative Names: Coramsine; SBP 002 cream - Solbec; SBP002; Solasonine/solamargine

Latest Information Update: 12 Nov 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Solbec Pharmaceuticals
  • Developer Freedom Eye
  • Class Antineoplastics; Immunotherapies; Skin disorder therapies; Solanaceous alkaloids
  • Mechanism of Action Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Malignant melanoma; Renal cancer

Highest Development Phases

  • No development reported Psoriasis; Renal cancer; Solid tumours

Most Recent Events

  • 05 Dec 2008 Solbec is now called Freedom Eye Limited
  • 19 May 2008 SBP 002 is available for licensing worldwide (http://www.solbec.com.au)
  • 04 Feb 2008 Use of SBP 002 for the single use treatment of a US patient with advanced RCC has been discontinued
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top